View ValuationEvonik Industries 향후 성장Future 기준 점검 3/6Evonik Industries (는) 각각 연간 25.9% 및 2.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 28.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.8% 로 예상됩니다.핵심 정보25.9%이익 성장률28.18%EPS 성장률Chemicals 이익 성장43.2%매출 성장률2.3%향후 자기자본이익률8.82%애널리스트 커버리지Good마지막 업데이트19 Jun 2026최근 향후 성장 업데이트Major Estimate Revision • Jun 19Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from €0.917 to €1.02. Revenue forecast steady at €14.5b. Net income forecast to grow 237% next year vs 52% growth forecast for Chemicals industry in Germany. Consensus price target broadly unchanged at €17.44. Share price was steady at €16.08 over the past week.Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.공시 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.공시 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).모든 업데이트 보기Recent updates분석 기사 • Jun 20Evonik Industries (XTRA:EVK) Stock Could Be 6.7% Undervalued After Efficiency PlanEvonik Industries (XTRA:EVK) has introduced a new efficiency plan that includes 3,200 job cuts by 2029 and an exit from its loss-making global polyester business, drawing fresh attention to the stock. See our latest analysis for Evonik Industries. The efficiency plan has arrived after a mixed period for Evonik Industries, with the 1-day share price return of 5.24% and 90-day share price return of 15.35% contrasting with a 1-year total shareholder return that is down 5.40%. This suggests...Major Estimate Revision • Jun 19Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from €0.917 to €1.02. Revenue forecast steady at €14.5b. Net income forecast to grow 237% next year vs 52% growth forecast for Chemicals industry in Germany. Consensus price target broadly unchanged at €17.44. Share price was steady at €16.08 over the past week.내러티브 업데이트 • Jun 12EVK: Methionine Pricing And Defensive Demand May Support Medium Term Re RatingAnalysts have raised the average price target for Evonik Industries to €20, up from the previous range of €17 to €19 in recent reports, reflecting updated views on earnings resilience, methionine pricing and defensiveness within European chemicals. Analyst Commentary The latest Street research on Evonik Industries presents a mixed picture, with both upgrades and downgrades across major brokers.내러티브 업데이트 • May 29EVK: Balanced Outlook As Rating Shifts And Defensive Demand Shape Future PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from €16.16 to €17.23. This change reflects a mix of higher price targets across the Street, ongoing concerns about mid term earnings and returns, and support from factors such as elevated methionine spreads and what analysts describe as more defensive demand.Upcoming Dividend • May 28Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 04 June 2026. Payment date: 08 June 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (3.7%).분석 기사 • May 15There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) EarningsEvonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...공시 • May 12Vary Tech, Evonik and Supezet Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality Ppo and Circular NaphthaVary Tech, a global leader in solid waste resource utilization, together with Evonik and SupeZET, officially launched a full-industry chain process package for chemically recycling waste plastics into high-quality Plastic Pyrolysis Oil (PPO) and circular naphtha. The core technology is Vary Tech's oxygen-free pyrolysis, developed over 20 years and six iterations. With a single-unit capacity of 150 tons/day and over 8,000 operating hours annually, it ensures high front-end stability. The PPO then enters Evonik's proprietary Rocket module for upgrading and impurity removal, followed by SupeZET's advanced hydrogenation and fractionation for deep refining. The complete chain — feedstock pretreatment, continuous pyrolysis, deep purification, and product offtake — directly outputs circular naphtha and high-quality PPO meeting international petrochemical standards. This ensures seamless entry into global petrochemical and low-carbon fuel supply chains, removing technical barriers to the high-end circular economy. As the core engine, Vary Tech's oxygen-free pyrolysis technology offers broad feedstock compatibility. Beyond waste plastics, it has been applied to waste tires, oil sludge, industrial hazardous waste, medical waste, and new energy solid waste, with over 100 commercial pyrolysis lines delivered globally. While building chemical recycling, Vary Tech also leads in mechanical recycling. Leveraging 16 years of self-operated plant experience and its "high-end equipment manufacturing + industrial operation" dual-drive model, Vary Tech showcased its AI-powered intelligent home appliance dismantling system at the exhibition. Achieving 200 units per hour — a global efficiency record — the system delivers high-purity separation of all e-waste categories. Vary Tech has empowered Haier, TCL, and Midea, providing green recycling services for over 130 million obsolete appliances worldwide. From mechanical to chemical recycling, Vary Tech is integrating global supply chain resources to deliver scalable, economical, and sustainable technical solutions for global climate action and circular economy goals.Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.27 (vs €0.50 in 1Q 2025)First quarter 2026 results: EPS: €0.27 (down from €0.50 in 1Q 2025). Revenue: €3.43b (down 9.3% from 1Q 2025). Net income: €125.0m (down 46% from 1Q 2025). Profit margin: 3.6% (down from 6.2% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.속보 • May 07Evonik Industries Stock Plunges 51% as Investors Await Crucial Earnings ReportEvonik Industries stock dropped 50.8% intraday on 5 May, reflecting a sharp loss of confidence ahead of its upcoming earnings release. The move highlights investor concern over profitability, operational headwinds and the resilience of the current dividend policy. The 8 May earnings announcement is seen as a key test of management’s outlook and plans through 2026. For you as an investor, the price shock signals that the market is bracing for potentially weak numbers or a reset in expectations, but without the earnings release yet, the exact triggers are not clear. The focus now is on whether management can provide a detailed picture of operational performance and explain how current conditions affect margins, cash flow and the dividend. The 2026 guidance will be especially important because it should show how Evonik plans to position its portfolio and manage costs over the medium term. Pay close attention to any commentary on capital allocation, possible changes to the payout, and the balance between investment and balance-sheet protection. This earnings call is likely to set the tone for how the stock is viewed until there is more concrete financial information.내러티브 업데이트 • May 03EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re RatingAnalysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.내러티브 업데이트 • Apr 19EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating PotentialAnalysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.공시 • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.내러티브 업데이트 • Apr 03EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €16.28, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 1.3% over the past three years.내러티브 업데이트 • Mar 20EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating PotentialThe analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.New Risk • Mar 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 43% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (176% payout ratio). Large one-off items impacting financial results.내러티브 업데이트 • Mar 06EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker ViewsAnalysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.내러티브 업데이트 • Feb 20EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.New Risk • Feb 06New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.3% per year for the foreseeable future. Minor Risks High level of debt (45% net debt to equity). Dividend is not well covered by earnings (dividend per share is over 5x earnings per share).Reported Earnings • Feb 06Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €1.36 (up from €0.48 in FY 2024). Revenue: €14.1b (down 7.2% from FY 2024). Net income: €634.0m (up 186% from FY 2024). Profit margin: 4.5% (up from 1.5% in FY 2024). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공시 • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.내러티브 업데이트 • Feb 06EVK: Weaker Pricing Power Will Drive Lower Future Earnings ExpectationsAnalysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.분석 기사 • Feb 06Evonik Industries AG (ETR:EVK) Not Flying Under The RadarWhen close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...내러티브 업데이트 • Jan 23EVK: Sector Caution And Margin Execution Will Shape Future Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.내러티브 업데이트 • Jan 08EVK: Pricing And Volume Execution Risk Will Pressure Future EarningsAnalysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.내러티브 업데이트 • Dec 23EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside PotentialEvonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.내러티브 업데이트 • Dec 09EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside PotentialThe analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.분석 기사 • Dec 04Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...내러티브 업데이트 • Nov 24EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform CollaborationEvonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.New Risk • Nov 06New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 5x earnings per share. Cash payout ratio: 120% Minor Risks High level of debt (45% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).내러티브 업데이트 • Nov 06EVK: Resilience And New Partnerships Will Drive Improved Revenue OutlookEvonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.공시 • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026Reported Earnings • Nov 05Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: €0.23 loss per share (down from €0.48 profit in 3Q 2024). Revenue: €3.39b (down 12% from 3Q 2024). Net loss: €106.0m (down 148% from profit in 3Q 2024). Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 8% per year.분석 기사 • Oct 30Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of InvestorsWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...내러티브 업데이트 • Oct 23Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic MovesEvonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.내러티브 업데이트 • Oct 09Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.공시 • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.공시 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.내러티브 업데이트 • Sep 25Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.분석 기사 • Sep 13Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...내러티브 업데이트 • Sep 04Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityWith both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.분석 기사 • Aug 28At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...Reported Earnings • Aug 03Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: €0.26 (up from €0.011 loss in 2Q 2024). Revenue: €3.50b (down 11% from 2Q 2024). Net income: €120.0m (up €125.0m from 2Q 2024). Profit margin: 3.4% (up from net loss in 2Q 2024). Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.분석 기사 • Jul 11Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...분석 기사 • Jun 26Evonik Industries (ETR:EVK) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).Reported Earnings • May 13First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: €0.50 (up from €0.33 in 1Q 2024). Revenue: €3.78b (flat on 1Q 2024). Net income: €233.0m (up 49% from 1Q 2024). Profit margin: 6.2% (up from 4.1% in 1Q 2024). Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates by 48%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.New Risk • Mar 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 0% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (237% payout ratio). Large one-off items impacting financial results.공시 • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.Reported Earnings • Mar 06Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.48 (up from €1.00 loss in FY 2023). Revenue: €15.2b (flat on FY 2023). Net income: €222.0m (up €687.0m from FY 2023). Profit margin: 1.5% (up from net loss in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.새로운 내러티브 • Nov 25Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins. Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.공시 • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025공시 • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.공시 • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공시 • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.공시 • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.공시 • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024공시 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).이익 및 매출 성장 예측XTRA:EVK - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202814,7485778281,6661112/31/202714,4495398321,6101312/31/202614,5025268101,561133/31/202613,7191576831,465N/A12/31/202514,0692656951,443N/A9/30/202514,265944561,269N/A6/30/202514,7074235131,325N/A3/31/202515,1382999411,720N/A12/31/202415,1572228731,713N/A9/30/202415,1632291,2161,978N/A6/30/202415,102-901,3282,072N/A3/31/202415,058-3569071,745N/A12/31/202315,267-4658011,594N/A9/30/202316,002-6048891,789N/A6/30/202317,109-2957081,675N/A3/31/202317,9952726731,568N/A12/31/202218,4885397851,650N/A9/30/202218,2389261741,100N/A6/30/202217,2319444101,284N/A3/31/202216,0958697501,630N/A12/31/202114,9557489291,815N/A9/30/202114,0787241,1962,086N/A6/30/202113,1246429841,920N/A3/31/202112,3145469701,924N/A12/31/202012,1994897711,727N/A9/30/202012,2706145731,482N/A6/30/202012,5856175071,403N/A3/31/202013,0656793701,259N/A12/31/201913,108753N/A1,321N/A9/30/201913,084506N/A1,517N/A6/30/201913,199624N/A1,619N/A3/31/201913,306673N/A1,826N/A12/31/201813,267686N/A1,760N/A9/30/201813,580841N/A1,708N/A6/30/201813,789797N/A1,877N/A3/31/201813,994788N/A1,567N/A12/31/201714,383713N/A1,551N/A9/30/201714,015723N/A1,667N/A6/30/201713,623718N/A1,449N/A3/31/201713,262656N/A1,708N/A12/31/201612,732748N/A1,769N/A9/30/201612,725758N/A1,774N/A6/30/201612,926725N/A1,982N/A3/31/201613,188981N/A1,863N/A12/31/201513,5071,008N/A1,971N/A9/30/201513,5351,027N/A1,776N/A6/30/201513,4131,004N/A1,373N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: EVK 의 연간 예상 수익 증가율(25.9%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: EVK 의 연간 수익(25.9%)이 German 시장(17.1%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: EVK 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: EVK 의 수익(연간 2.3%)이 German 시장(연간 6.7%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: EVK 의 수익(연간 2.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: EVK의 자본 수익률은 3년 후 8.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/21 11:32종가2026/06/19 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Evonik Industries AG는 27명의 분석가가 다루고 있습니다. 이 중 13명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Anil ShenoyBarclaysAndreas HeineBarclaysSebastian BrayBerenberg24명의 분석가 더 보기
Major Estimate Revision • Jun 19Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from €0.917 to €1.02. Revenue forecast steady at €14.5b. Net income forecast to grow 237% next year vs 52% growth forecast for Chemicals industry in Germany. Consensus price target broadly unchanged at €17.44. Share price was steady at €16.08 over the past week.
Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.
Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.
공시 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
공시 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).
분석 기사 • Jun 20Evonik Industries (XTRA:EVK) Stock Could Be 6.7% Undervalued After Efficiency PlanEvonik Industries (XTRA:EVK) has introduced a new efficiency plan that includes 3,200 job cuts by 2029 and an exit from its loss-making global polyester business, drawing fresh attention to the stock. See our latest analysis for Evonik Industries. The efficiency plan has arrived after a mixed period for Evonik Industries, with the 1-day share price return of 5.24% and 90-day share price return of 15.35% contrasting with a 1-year total shareholder return that is down 5.40%. This suggests...
Major Estimate Revision • Jun 19Consensus EPS estimates increase by 12%The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from €0.917 to €1.02. Revenue forecast steady at €14.5b. Net income forecast to grow 237% next year vs 52% growth forecast for Chemicals industry in Germany. Consensus price target broadly unchanged at €17.44. Share price was steady at €16.08 over the past week.
내러티브 업데이트 • Jun 12EVK: Methionine Pricing And Defensive Demand May Support Medium Term Re RatingAnalysts have raised the average price target for Evonik Industries to €20, up from the previous range of €17 to €19 in recent reports, reflecting updated views on earnings resilience, methionine pricing and defensiveness within European chemicals. Analyst Commentary The latest Street research on Evonik Industries presents a mixed picture, with both upgrades and downgrades across major brokers.
내러티브 업데이트 • May 29EVK: Balanced Outlook As Rating Shifts And Defensive Demand Shape Future PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from €16.16 to €17.23. This change reflects a mix of higher price targets across the Street, ongoing concerns about mid term earnings and returns, and support from factors such as elevated methionine spreads and what analysts describe as more defensive demand.
Upcoming Dividend • May 28Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 04 June 2026. Payment date: 08 June 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (3.7%).
분석 기사 • May 15There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) EarningsEvonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
공시 • May 12Vary Tech, Evonik and Supezet Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality Ppo and Circular NaphthaVary Tech, a global leader in solid waste resource utilization, together with Evonik and SupeZET, officially launched a full-industry chain process package for chemically recycling waste plastics into high-quality Plastic Pyrolysis Oil (PPO) and circular naphtha. The core technology is Vary Tech's oxygen-free pyrolysis, developed over 20 years and six iterations. With a single-unit capacity of 150 tons/day and over 8,000 operating hours annually, it ensures high front-end stability. The PPO then enters Evonik's proprietary Rocket module for upgrading and impurity removal, followed by SupeZET's advanced hydrogenation and fractionation for deep refining. The complete chain — feedstock pretreatment, continuous pyrolysis, deep purification, and product offtake — directly outputs circular naphtha and high-quality PPO meeting international petrochemical standards. This ensures seamless entry into global petrochemical and low-carbon fuel supply chains, removing technical barriers to the high-end circular economy. As the core engine, Vary Tech's oxygen-free pyrolysis technology offers broad feedstock compatibility. Beyond waste plastics, it has been applied to waste tires, oil sludge, industrial hazardous waste, medical waste, and new energy solid waste, with over 100 commercial pyrolysis lines delivered globally. While building chemical recycling, Vary Tech also leads in mechanical recycling. Leveraging 16 years of self-operated plant experience and its "high-end equipment manufacturing + industrial operation" dual-drive model, Vary Tech showcased its AI-powered intelligent home appliance dismantling system at the exhibition. Achieving 200 units per hour — a global efficiency record — the system delivers high-purity separation of all e-waste categories. Vary Tech has empowered Haier, TCL, and Midea, providing green recycling services for over 130 million obsolete appliances worldwide. From mechanical to chemical recycling, Vary Tech is integrating global supply chain resources to deliver scalable, economical, and sustainable technical solutions for global climate action and circular economy goals.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.27 (vs €0.50 in 1Q 2025)First quarter 2026 results: EPS: €0.27 (down from €0.50 in 1Q 2025). Revenue: €3.43b (down 9.3% from 1Q 2025). Net income: €125.0m (down 46% from 1Q 2025). Profit margin: 3.6% (down from 6.2% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
속보 • May 07Evonik Industries Stock Plunges 51% as Investors Await Crucial Earnings ReportEvonik Industries stock dropped 50.8% intraday on 5 May, reflecting a sharp loss of confidence ahead of its upcoming earnings release. The move highlights investor concern over profitability, operational headwinds and the resilience of the current dividend policy. The 8 May earnings announcement is seen as a key test of management’s outlook and plans through 2026. For you as an investor, the price shock signals that the market is bracing for potentially weak numbers or a reset in expectations, but without the earnings release yet, the exact triggers are not clear. The focus now is on whether management can provide a detailed picture of operational performance and explain how current conditions affect margins, cash flow and the dividend. The 2026 guidance will be especially important because it should show how Evonik plans to position its portfolio and manage costs over the medium term. Pay close attention to any commentary on capital allocation, possible changes to the payout, and the balance between investment and balance-sheet protection. This earnings call is likely to set the tone for how the stock is viewed until there is more concrete financial information.
내러티브 업데이트 • May 03EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re RatingAnalysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
내러티브 업데이트 • Apr 19EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating PotentialAnalysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
공시 • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.
내러티브 업데이트 • Apr 03EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €16.28, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 1.3% over the past three years.
내러티브 업데이트 • Mar 20EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating PotentialThe analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
New Risk • Mar 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 43% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (176% payout ratio). Large one-off items impacting financial results.
내러티브 업데이트 • Mar 06EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker ViewsAnalysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
내러티브 업데이트 • Feb 20EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.
New Risk • Feb 06New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.3% per year for the foreseeable future. Minor Risks High level of debt (45% net debt to equity). Dividend is not well covered by earnings (dividend per share is over 5x earnings per share).
Reported Earnings • Feb 06Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €1.36 (up from €0.48 in FY 2024). Revenue: €14.1b (down 7.2% from FY 2024). Net income: €634.0m (up 186% from FY 2024). Profit margin: 4.5% (up from 1.5% in FY 2024). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공시 • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
내러티브 업데이트 • Feb 06EVK: Weaker Pricing Power Will Drive Lower Future Earnings ExpectationsAnalysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
분석 기사 • Feb 06Evonik Industries AG (ETR:EVK) Not Flying Under The RadarWhen close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
내러티브 업데이트 • Jan 23EVK: Sector Caution And Margin Execution Will Shape Future Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
내러티브 업데이트 • Jan 08EVK: Pricing And Volume Execution Risk Will Pressure Future EarningsAnalysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
내러티브 업데이트 • Dec 23EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside PotentialEvonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
내러티브 업데이트 • Dec 09EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside PotentialThe analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
분석 기사 • Dec 04Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
내러티브 업데이트 • Nov 24EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform CollaborationEvonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.
New Risk • Nov 06New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 5x earnings per share. Cash payout ratio: 120% Minor Risks High level of debt (45% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).
내러티브 업데이트 • Nov 06EVK: Resilience And New Partnerships Will Drive Improved Revenue OutlookEvonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
공시 • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026
Reported Earnings • Nov 05Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: €0.23 loss per share (down from €0.48 profit in 3Q 2024). Revenue: €3.39b (down 12% from 3Q 2024). Net loss: €106.0m (down 148% from profit in 3Q 2024). Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 8% per year.
분석 기사 • Oct 30Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of InvestorsWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
내러티브 업데이트 • Oct 23Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic MovesEvonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
내러티브 업데이트 • Oct 09Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
공시 • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026
Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.
공시 • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
내러티브 업데이트 • Sep 25Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
분석 기사 • Sep 13Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
내러티브 업데이트 • Sep 04Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityWith both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
분석 기사 • Aug 28At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...
Reported Earnings • Aug 03Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: €0.26 (up from €0.011 loss in 2Q 2024). Revenue: €3.50b (down 11% from 2Q 2024). Net income: €120.0m (up €125.0m from 2Q 2024). Profit margin: 3.4% (up from net loss in 2Q 2024). Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
분석 기사 • Jul 11Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...
분석 기사 • Jun 26Evonik Industries (ETR:EVK) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).
Reported Earnings • May 13First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: €0.50 (up from €0.33 in 1Q 2024). Revenue: €3.78b (flat on 1Q 2024). Net income: €233.0m (up 49% from 1Q 2024). Profit margin: 6.2% (up from 4.1% in 1Q 2024). Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates by 48%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
New Risk • Mar 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 0% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (237% payout ratio). Large one-off items impacting financial results.
공시 • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
Reported Earnings • Mar 06Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.48 (up from €1.00 loss in FY 2023). Revenue: €15.2b (flat on FY 2023). Net income: €222.0m (up €687.0m from FY 2023). Profit margin: 1.5% (up from net loss in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
새로운 내러티브 • Nov 25Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
공시 • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025
공시 • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025
Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).
Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
공시 • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.
Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공시 • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.
공시 • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.
Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
공시 • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024
공시 • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).